SAN JOSE, Calif., Aug. 24 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices
for the minimally invasive treatment of venous reflux disease, today
announced its plans to present at the Roth Capital Partners 5th Annual New
York Conference, to be held September 5-6, 2007, at the Westin New York at
Times Square, New York City.
VNUS' presentation is currently scheduled for 11:30 a.m. ET on
Thursday, September 6, and will be webcast on the corporate website at
http://ir.vnus.com/medialist.cfm. The management speakers will be President
and Chief Executive Officer Brian Farley and Vice President, Finance and
Administration and Chief Financial Officer Tim Marcotte.
About VNUS Medical Technologies, Inc.
Founded in 1995 and headquartered in San Jose, California, VNUS Medical
Technologies (Nasdaq: VNUS - News) is a worldwide leader in medical devices
for the minimally invasive treatment of venous reflux disease, a
progressive condition that causes the varicose veins afflicting 25 million
Americans. The pioneering company in the field, VNUS now offers the
ClosureFAST system, which consists of a proprietary radiofrequency (RF)
generator and proprietary disposable endovenous catheters and devices to
close diseased veins through the application of temperature-controlled RF
energy. VNUS devices have been used in more than 200,000 procedures
worldwide. For more information, please visit http://www.vnus.com.
SOURCE VNUS(R) Medical Technologies, Inc.
 back to top
Related links:
http://www.vnus.com
CONTACT:
Tim Marcotte, Vice President, Finance and
Administration, Chief Financial Officer of VNUS Medical
Technologies, Inc., +1-408-473-1199, ir@vnus.com
|
